1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. KYMERA THERAPEUTICS INC
Kymera Therapeutics Inc XNAS: KYMR

Kymera Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' li...

Read More
57.90 1.90 (3.39%)
New 52W High today
612.0K
XNAS Volume

XNAS 03 Oct, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
9.0 / 100
Momentum Score
Technically Bullish
76.0 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
64
1Yr Price target upside is 11%
21 analysts

20

S

8

W

6

O

0

T

SWOT Analysis

Kymera Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..